Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 18241 - 18260 out of 554189 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AD02) tacrolimus (adm: O) | Prograf 5 mg capsule, 50 | Capsule 5 mg, 50 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AstellasPharmaAustraliaPtyLtd |
| Australia | (L04AD02) tacrolimus (adm: O) | Tacrograf 5 mg capsule, 50 | Capsule 5 mg, 50 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ArrowPharmaPtyLtd |
| Australia | (L04AD02) tacrolimus (adm: O) | Tacrolimus (Pharmacor) 5 mg capsule, 50 | Capsule 5 mg, 50 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AD02) tacrolimus (adm: O) | Tacrolimus (Sandoz) 5 mg capsule, 50 | Capsule 5 mg, 50 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (L04AD02) tacrolimus (adm: O) | Tacrolimus XR (Sandoz) 500 microgram modified release capsule, 30 | Capsule 0.5 mg (once daily prolonged release), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (L04AG03) natalizumab (adm: P) | Tysabri 300 mg/15 mL injection, 15 mL vial | Solution concentrate for I.V. infusion 300 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenAustraliaPtyLtd |
| Australia | (L04AG03) natalizumab (adm: P) | Tysabri 150 mg/mL injection, 2 x 1 mL syringes | Injection 150 mg in 1 mL single dose pre-filled syringe, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenAustraliaPtyLtd |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG06) alemtuzumab (adm: P) | Lemtrada 12 mg/1.2 mL injection, 1.2 mL vial | Solution concentrate for I.V. infusion 12 mg in 1.2 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | sanofi-aventisAustraliaPtyLtd |
| Australia | (L04AG06) alemtuzumab (adm: P) | Lemtrada 12 mg/1.2 mL injection, 1.2 mL vial | Solution concentrate for I.V. infusion 12 mg in 1.2 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | sanofi-aventisAustraliaPtyLtd |
| Australia | (L04AG08) ocrelizumab (adm: P) | Ocrevus 300 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 300 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | RocheProductsPtyLtd |
| Australia | (L04AG08) ocrelizumab (adm: P) | Ocrevus SC 920 mg/23 mL injection, 23 mL vial | Solution for subcutaneous injection 920 mg in 23 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | RocheProductsPtyLtd |
| Australia | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | Saphnelo 300 mg/2 mL injection, 2 mL vial | Solution concentrate for I.V. infusion 300 mg in 2 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | AstraZenecaPtyLtd |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 500 microgram tablet, 100 | Tablet 0.5 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
Pages
